BioVie Inc. (BIVI) News
Filter BIVI News Items
BIVI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BIVI News Highlights
- BIVI's 30 day story count now stands at 2.
- Over the past 11 days, the trend for BIVI's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- FL and RAIL are the most mentioned tickers in articles about BIVI.
Latest BIVI News From Around the Web
Below are the latest news stories about BIOVIE INC that investors may wish to consider to help them evaluate BIVI as an investment opportunity.
Rail Vision and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TVORLANDO, FL / ACCESSWIRE / December 22, 2023 / RedChip Companies will air interviews with Rail Vision (NASDAQ:RVSN) and BioVie, Inc. (NASDAQ:BIVI) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, December ... |
BioVie Inc. (BIVI) Loses -46.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerThe heavy selling pressure might have exhausted for BioVie Inc. (BIVI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal. |
The Zacks Analyst Blog Highlights Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVieAvidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie are included in this Analyst Blog. |
Biotech Stock Roundup: RNA Up on BMY Deal Expansion, BIVI Down on Setback & MoreRegulatory and pipeline updates from Avidity Biosciences, Inc. (RNA) and BioVie (BIVI) are in the spotlight this week. |
BioVie (BIVI) Falls 61% Despite Upbeat Alzheimer's Study DataBioVie (BIVI) stock plunges 61% in spite of positive phase III Alzheimer's Disease study results due to significant study conduct violations and protocol deviations reported by the company. |
Why Is BioVie (BIVI) Stock Down 63% Today?BioVie stock is falling after its Phase 3 clinical trial of its Alzheimer’s treatment candidate failed to show statistical significance. |
Why Is Farfetch (FTCH) Stock Down 50% Today?Farfetch stock is falling on Wednesday as shares of FTCH have been volatile alongside going private reports, delayed earnings and more. |
Why Is Vivos Therapeutics (VVOS) Stock Up 290% Today?Vivos Therapeutics stock is rocketing higher on Wednesday with heavy trading of VVOS shares following approval from the FDA! |
BioVie Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer’s DiseaseTable 1 Change from Baseline Figure 2 Improvements in Clinical Dementia Rating-Sum of Boxes Figure 3 Decrease of Neuroinflammatory Processes Figure 4 Age Deceleration Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker Endpoints Sponsor Identified Issues Relating to Significant GCP Violations and Protocol Deviations, Which Allowed for Data from Only a Subset of Enrolled Patients to be Included in t |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday! |